Sponsored By

This activity was supported by an unrestricted educational grant grant from Biogen MA, Inc. and PTC Therapeutics, Inc.

{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Therapeutic Update on Neuromuscular Disorders Conference Highlights from 2018 - Site registration is required - Please add to planner

Description

OlogyImage

What are the most important recent developments in the treatment of spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD)? In this 1-hour educational webcast, two leading experts review the latest data presented at major conferences during 2018. Dr. Basil Darras and Dr. John Brandsema discuss the latest clinical findings relating to new and emerging treatments for SMA and for DMD, and highlight the implications for daily practice.

Target Audience

This activity has been designed to meet the educational needs of neurologists, neuromuscular disease specialists, pulmonologists, physical therapists, nurses, and other HCPs involved in the management of patients with NMDs

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. List the pathophysiology and classification of different NMDs, and the implications for diagnosis
  2. Outline the mechanisms of action of current and emerging therapies for NMDs
  3. Discuss the latest important clinical trial data on current and emerging therapies for spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD)
  4. Summarize how the new research findings presented at the major neurology conferences could influence the way that HCPs diagnose and treat patients with NMDs.
Price: FREE

Credits:

  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: WEB2019
Published: March 2019
Expires: 3/6/2020
Passing Score: 6/8 (75%)
Authors: Dr. Basil Darras, Director of the Neuromuscular Center, Boston Children's Hospital, Boston, MA

Dr. John Brandsema, Neuromuscular Section Head, Children's Hospital of Philadelphia, Philadelphia, PA
Specialties: Neurology